Cargando…

Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report

BACKGROUND: The co-occurrence of Anti-phospholipase A2 receptor-associated membranous nephropathy (anti-PLA2R-MN) and human immunodeficiency virus (HIV) infection is a rare clinical scenario, presenting significant challenges in terms of management and treatment. CASE SUMMARY: A 32-year-old Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jin-Ling, Sun, Yan-Ling, Kang, Zhe, Zhang, Sheng-Kun, Yu, Chun-Xin, Zhang, Wan, Xie, Hua, Lin, Hong-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445080/ https://www.ncbi.nlm.nih.gov/pubmed/37621578 http://dx.doi.org/10.12998/wjcc.v11.i22.5309

Ejemplares similares

Telitacicept for autoimmune nephropathy
por: Cai, Jingjing, et al.
Publicado: (2023)

Case report: Successful treatment of refractory membranous nephropathy with telitacicept
por: Zhang, Lei, et al.
Publicado: (2023)

Role of telitacicept in the treatment of IgA nephropathy
por: Wu, Lijun, et al.
Publicado: (2023)

Efficacy and safety of Telitacicept in patients with IgA nephropathy
por: Liang, Dongrui, et al.
Publicado: (2023)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

Anti-phospholipase A2 receptor antibodies in membranous nephropathy
por: Lee, Sangho
Publicado: (2018)

Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy
por: Zhang, Qiuhua, et al.
Publicado: (2017)

Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy
por: Diaz, Montserrat, et al.
Publicado: (2018)

Anti-Phospholipase A2 Receptor in Nonlupus Patients with Membranous Nephropathy and Crescents
por: Zuo, Yiqin, et al.
Publicado: (2021)

Anti-phospholipase A2 Receptor Antibody-Negative Membranous Nephropathy in Pregnancy
por: Saleem, Maryam, et al.
Publicado: (2023)

Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy
por: Fu, Keying, et al.
Publicado: (2022)

A new promising biological agent for refractory lupus nephritis: Telitacicept
por: Liu, Shuangyan, et al.
Publicado: (2023)

Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy
por: Ardalan, Mohammad Reza
Publicado: (2013)

Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy
por: Akiyama, Shin’ichi, et al.
Publicado: (2014)

Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
por: Ardalan, Mohammad-Reza, et al.
Publicado: (2013)

Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy
por: Xu, Ning-Xin, et al.
Publicado: (2017)

Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan
por: Liu, Yu-Huei, et al.
Publicado: (2010)

Role of Anti-Phospholipase A(2) Receptor Antibodies in the Differential Diagnosis of Diabetic and Membranous Nephropathy
por: Pocivalnik, Mirjam, et al.
Publicado: (2013)

Anti-Phospholipase A(2) Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy
por: Zhu, Quansheng
Publicado: (2016)

Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
por: Barrett, Christine, et al.
Publicado: (2020)

Autoantibodies against Phospholipase A(2) Receptor in Korean Patients with Membranous Nephropathy
por: Oh, Yun Jung, et al.
Publicado: (2013)

Ischemic stroke in anti-phospholipase A2 receptor antibody-positive primary membranous nephropathy: clinical and neuroimaging characteristics
por: Zhang, Jing, et al.
Publicado: (2020)

Good efficacy achieved by telitacicept, corticosteroids and immunosuppressants in the treatment of SLE combined with MOG-AD
por: Tian, Mengxue, et al.
Publicado: (2023)

Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy
por: Surindran, Sheena, et al.
Publicado: (2012)

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
por: Song, Eun Joo, et al.
Publicado: (2018)

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2020)

Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
por: Zhang, Xian-Wen, et al.
Publicado: (2021)

Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody
por: Guo, Wenkai, et al.
Publicado: (2020)

Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study
por: Jin, Hui-Zhi, et al.
Publicado: (2023)

Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B‐Lymphocyte Stimulating Factor Receptor‐Antibody Fusion Protein, in Healthy Chinese Subjects
por: Xie, Jing, et al.
Publicado: (2022)

Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies
por: Ren, Yijun, et al.
Publicado: (2023)

Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy
por: Li, Chao, et al.
Publicado: (2018)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
por: Jullien, Perrine, et al.
Publicado: (2017)

A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies
por: Mathew, David, et al.
Publicado: (2021)

An Anti-Phospholipase A(2) Receptor Quantitative Immunoassay and Epitope Analysis in Membranous Nephropathy Reveals Different Antigenic Domains of the Receptor
por: Behnert, Astrid, et al.
Publicado: (2013)

New antigens involved in membranous nephropathy beyond phospholipase A2 receptor
por: Salvadori, Maurizio, et al.
Publicado: (2022)

Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy
por: Vink, Coralien H., et al.
Publicado: (2022)

Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study
por: Yin, Peihong, et al.
Publicado: (2020)

Phospholipase A2 receptor is associated with hypercoagulable status in membranous nephropathy: a narrative review
por: Lu, Xu, et al.
Publicado: (2022)

Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy
por: Dong, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pn6rdaviv1r9dql3ntj570deum